点击图片查看原图
咨询热线：020-82574011 13802525278 13710007117
广州健仑生物科技有限公司是一家专注的诊断试剂领域生产、销售的厂商，与多家国际知名诊断公司进行强强联手，本公司为澳大利亚PANBIO、美国CorteZ、美国BinaxNow、日本富士、日本生研等多家企业在中国地区的总代理商及负责售后服务技术支持工作。
全球公认最好的登革热诊断产品，世界销售遥遥领先的品牌.拥有FDA、CE欧盟认证及众多专利
|
从发病率和死亡率与经济成本来看，登革热为全球最严重的由蚊虫传播的病毒性疾病。该病毒主要是通过埃及伊蚊传播，超过100个国家报告过登革热爆发，有2.5亿人生活在登革高感染区，每年会发生5000万到1亿例登革出血热，200000-500000例登革感染者最终发展为登革出血热，平均有5%的登革出血热患者会死亡。 |
||||||||||||||||||||||||||||||||||||||
| 三、Panbio®登革热全线产品 | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
| 三、Panbio®产品具体介绍 | ||||||||||||||||||||||||||||||||||||||
|
1、登革热快速检测试剂（Dengue Duo Cassette） |
||||||||||||||||||||||||||||||||||||||
| 用于定性的快速检测人群血清、血浆或全血中登革病毒的IgM及IgG抗体。可在15分钟内检测结果。 | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
| 2、登革IgM捕捉ELISA（Dengue IgM Capture） | ||||||||||||||||
|
用于定性的检测人群血清中登革病毒的IgM抗体，用于临床实验室对具有持续发烧的登革热症状的病人的辅助诊断。 |
||||||||||||||||
|
广州健仑生物科技有限公司为Panbio品牌中国地区总代理，负责该产品的总经销及售后服务工作. |
||||||||||||||||
| 4、登革早期ELISA（Dengue Early ELISA） | ||||||||||||||||
| 用于定性检测血清中登革病毒的NS1抗原（血清型1、2、3及4型）。用于临床实验室对有持续发烧的登革热症状病人的辅助性诊断。 | ||||||||||||||||
|
||||||||||||||||
|
5、登革IgG间接ELISA（Dengue IgG Indirect） |
||||||||||||||||
|
用于定性检测血清中登革病毒（血清型1、2、3及4型）的IgG抗体，用于临床实验室对具有持续发烧的登革感染症状或接触史的患者的辅助性诊断。 |
||||||||||||||||
|
||||||||||||||||
| 6、登革IgM & IgG联检ELISA（Dengue Duo IgM & IgG Capture） | ||||||||||||||||
|
用于定性检测血清中登革病毒的IgM和IgG抗体。可以区分原发感染与继发感染。 |
||||||||||||||||
|
||||||||||||||||
1、1988年成立，2001年澳大利亚证券交易所上市.
1）全球关于虫媒感染性疾病及热带感染性疾病的专业供货商
2）产品面向虫媒感染性疾病的监测，在国内疾控系统具有极高的认知和认可度
2、2010年销售全球800万检测，为30多种疾病提供诊断
3、革新的历史及面向市场需求提供回应；
1）登革热：全球第一个商用试剂盒，目前拥有最先机，最完善的产品线及售后服务系统
2）罗斯河热：全球第一个商用试剂盒
3）系尼罗河病毒：第一个获得FDA批准的试剂盒
新产品
恙虫热快速检测试剂/检测卡
日本脑膜炎-登革热联检ELISA等
Panbio登革热诊断试剂盒
PANBIO Introduction Diagnosis
Panbio empowers people to take control of their health by actively integrating diagnostics and health management solutions to provide timely, actionable information in a range of environments from hospital to home.
We provide in vitro diagnostics in the fields of cardiovascular, infectious diseases, women's health, prenatal care, drugs of abuse and oncology. We support healthcare workers and patients by developing simple diagnostic equipment to ensure better quality in both inpatient and outpatient care.
Through the strategic acquisition of a number of companies, we have steadily grown and have expanded our product and service offering. We are a market leader engaged in health care management programs and services and offer comprehensive support for health care professionals and patients across the globe.
We are a global leader in the field of rapid diagnostic tests which are designed to improve the quality of patient care. Specific product lines include tests for the rapid and early diagnosis of myocardial infarction, influenza, acute kidney damage, HIV infection, and for the exclusion of acute risk of premature labour and delivery. We also support the patients' ability to self-manage a number of common health issues, for example by offering an easy-to-use device to monitor blood coagulation. A device patients may use in the home.
By supplying products that are accurate, effective, consistent and reliable for use in both the home and clinical environments, Alere is enabling doctors and patients to better connect with each other and provide the information necessary to make better healthcare decisions.
China's general agent：
GuangZhou Jianlun Biology Technology Co.，Ltd
Tel：+86-020-82574011/ Fax：+86-020-32206070 E-mail：Service@jianlun.com
